# A Study of Once Monthly Intravenous or Subcutaneous Mircera in Participants With Chronic Kidney Disease on Hemodialysis.

> **NCT00717821** · PHASE3 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 421 (actual)

## Conditions studied

- Anemia

## Interventions

- **DRUG:** Methoxy Polyethylene Glycol-epoetin Beta
- **DRUG:** Epoetin Beta
- **DRUG:** Darbepoetin Alfa

## Key facts

- **NCT ID:** NCT00717821
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 421 (ACTUAL)
- **Last updated:** 2021-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00717821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00717821, "A Study of Once Monthly Intravenous or Subcutaneous Mircera in Participants With Chronic Kidney Disease on Hemodialysis.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00717821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*